NABI BIOPHARMACEUTICALS 4
4 · NABI BIOPHARMACEUTICALS · Filed May 23, 2005
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Purchase
Common Stock
2005-05-20$12.17/sh+1,000$12,170→ 3,630.676 total
Signature
/s/ James E. Dawson, as attorney-in-fact|2005-05-23